RHOJ derived peptide promotes chemosensitivity by inhibiting glutamine metabolism in gastric cancer

Authors:

Abstract
Chemoresistance is a cause of chemotherapy failure in gastric cancer (GC) treatment. Recent studies have shown that the dysregulation of glutamine metaboli

This publication has 53 references indexed in Scilit: